RankingsPricing
  1. US-listed companies
  2. CAPRICOR THERAPEUTICS, INC.
  3. Financials
  4. EBITDA margin (%)

CAPRICOR THERAPEUTICS, INC.CAPR

Market cap
$1.2B
P/E ratio
SummaryFinancials
Period EndEBITDA margin (%) YoY (%)
Dec 31, 2024-184.7+102.14%
Dec 31, 2023-91.4-92.01%
Dec 31, 2022-1,143-86.47%
Dec 31, 2021-8,449.5+93.52%
Dec 31, 2020-4,366.2+480.29%
Dec 31, 2019-752.4-17.10%
Dec 31, 2018-907.6+90.28%
Dec 31, 2017-477+13.19%
Dec 31, 2016-421.4+86.00%
Dec 31, 2015-226.6+81.47%
Dec 31, 2014-124.8+20.06%
Dec 31, 2012-104-58.28%
Dec 31, 2011-249.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)